Listed as “Cartography Biosciences”
- First observed:
- 29 Oct 2026
- Investment announced:
- Date not recorded
Cartography Biosciences develops computational approaches to discovering therapeutics.
Cartography Biosciences uses cellular data from healthy and diseased tissues in its therapeutic discovery platforms. It applies machine learning and computational biology to identify targets and combinations associated with specific cells. The company is building molecules using its drug discovery engine.
Bio + Health
Category source ↗Checked
Some source history is available; coverage remains limited.
Coverage describes public evidence. Points require a qualifying milestone after your pick.
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
Listed as “Cartography Biosciences”
No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.